Citadel Advisors’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-498
| Closed | -$16K | – | 6891 |
|
|
2022
Q4 | $16K | Buy |
+498
| New | +$16K | ﹤0.01% | 5585 |
|
|
2022
Q3 | – | Sell |
-5,371
| Closed | -$226K | – | 7031 |
|
|
2022
Q2 | $226K | Buy |
5,371
+2,219
| +70% | +$93.4K | ﹤0.01% | 4903 |
|
|
2022
Q1 | $214K | Buy |
3,152
+263
| +9% | +$17.9K | ﹤0.01% | 5251 |
|
|
2021
Q4 | $351K | Buy |
+2,889
| New | +$351K | ﹤0.01% | 4962 |
|
|
2021
Q3 | – | Sell |
-974
| Closed | -$268K | – | 7353 |
|
|
2021
Q2 | $268K | Sell |
974
-811
| -45% | -$223K | ﹤0.01% | 5323 |
|
|
2021
Q1 | $382K | Buy |
1,785
+652
| +58% | +$140K | ﹤0.01% | 4819 |
|
|
2020
Q4 | $274K | Buy |
+1,133
| New | +$274K | ﹤0.01% | 4299 |
|
|
2020
Q2 | – | Sell |
-511
| Closed | -$38K | – | 5475 |
|
|
2020
Q1 | $38K | Buy |
+511
| New | +$38K | ﹤0.01% | 4578 |
|